Duration of antiretroviral regimens in treatment-experienced patients in clinical practice

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice

Bibliographic Details
Main Authors:	Cano Jose, Larisgoitia Arantza, Romera Isabel, Lopez Nicolas, Paniagua Sergio, Vilaplana Vicente, Saez Maria
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Retrovirology

Similar Items

Modern antiretroviral regimens
by: A. V. Kravchenko
Published: (2016-12-01)

Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens
by: Salvatore Martini, et al.
Published: (2023-07-01)

Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound
by: Guan-Jhou Chen, et al.
Published: (2023-10-01)

Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals
by: Benjamin R Phelps, et al.
Published: (2010-01-01)

Antiretroviral regimens for preventing HIV infection in infants
by: René E. Ekpini, et al.
Published: (2005-07-01)

SELECTION OF AN ANTIRETROVIRAL REGIMEN BASED ON THE RESISTANCE DATA
by: O. G. YURIN, et al.
Published: (2017-05-01)

Characteristics of HIV antiretroviral regimen and treatment adherence
by: Vera Lúcia da Silveira, et al.

Encoding, storage and judgment of experienced frequency and duration
by: Tilmann Betsch, et al.
Published: (2010-08-01)

Encoding, storage and judgment of experienced frequency and duration
by: Tilmann Betsch, et al.
Published: (2010-08-01)

Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
by: Hartmut Krentz PhD, et al.
Published: (2019-01-01)

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search
by: Rosa Romero-Jimenez, et al.
Published: (2022-03-01)

Towards an ideal antiretroviral regimen for the global HIV epidemic
by: Beatriz Grinsztejn, et al.
Published: (2017-07-01)

Effectiveness of antiretroviral therapy in the single-tablet regimen era
by: Juliana de Oliveira Costa, et al.
Published: (2018-11-01)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
by: Comolli Giuditta, et al.
Published: (2011-03-01)

Virologic and Immunologic Effectiveness at 48 Weeks of Darunavir–Ritonavir-Based Regimens in Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice
by: Fernando Martín Biscione MD, PhD, et al.
Published: (2014-01-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
by: Paton, N, et al.
Published: (2014)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
by: Paton, N, et al.
Published: (2014)

Effectiveness of four antiretroviral regimens for treating people living with HIV.
by: Aracele Tenório de Almeida E Cavalcanti, et al.
Published: (2020-01-01)

Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
by: Reuben Granich, et al.
Published: (2018-05-01)

Persistent intracellular HIV transcription in individuals on stable antiretroviral regimens
by: Dimitrios Pilalas, et al.
Published: (2018-05-01)

Medication possession ratio predicts antiretroviral regimens persistence in Peru.
by: Jorge L Salinas, et al.
Published: (2013-01-01)

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting
by: Paolo Maggi, et al.
Published: (2023-07-01)

Psychophysiology of duration estimation in experienced mindfulness meditators and matched controls
by: Simone eOtten, et al.
Published: (2015-08-01)

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens
by: Paolo Maggi, et al.
Published: (2023-04-01)

Which antiretroviral regimen is associated with higher adherence in Brazil? A comparison of single, multi, and dolutegravir-based regimens
by: Tarsilla Spezialli Cardoso, et al.

Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients
by: Hiroyuki Tanaka, et al.
Published: (2014-07-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
by: Patrick S Sullivan, et al.
Published: (2007-01-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Incidence and predictors of first line antiretroviral regimen modification in western Kenya.
by: Seth Inzaule, et al.
Published: (2014-01-01)

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
by: Anchalee Avihingsanon, et al.
Published: (2017-08-01)

Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients
by: Crina Fofiu, et al.
Published: (2019-01-01)

Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients
by: Parya Basimi, et al.
Published: (2023-04-01)

Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19
by: Xudan Chen, et al.
Published: (2020-09-01)

Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
by: Sergio Serrano-Villar, et al.
Published: (2022-06-01)

Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials
by: Frank Spinelli, et al.
Published: (2021-07-01)

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
by: Boris K Tchounga, et al.
Published: (2020-01-01)

Impact of adverse events of antiretroviral treatment on regimen change and mortality in Ugandan children
by: Ntambwe Malangu, et al.
Published: (2010-06-01)

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
by: Edwin DeJesus, et al.
Published: (2019-05-01)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
by: Analú Correa, et al.
Published: (2020-01-01)